!!Nancy Y. Ip - Biography
\\
Nancy Ip has made fundamental contributions to our understanding of neuronal communication and the biology of Alzheimer’s disease (AD). Her groundbreaking studies on the signaling mechanisms of receptor tyrosine kinases in synaptic plasticity, which is important for learning and memory; and the role of cytokine receptors in innate immune regulation, which is important for brain homeostasis, have expanded our knowledge of essential brain functions and unveiled new therapeutic approaches for AD, leading to the development of novel therapeutic candidates currently in clinical development. Furthermore, Ip has advanced human genetic studies of AD within the Chinese ethnic population, addressing a critical research gap for non-European individuals. Her work established the first multiomics databases for this demographic and identified novel genetic risk factors associated with the disease. She also led the first large-scale blood protein biomarker study for AD, resulting in development of innovative tests for early diagnosis and monitoring. Additionally, Ip has pioneered CRISPR-Cas9 technology for developing novel gene therapies for familial AD. Overall, Ip's diverse and impactful research, particularly her focused efforts on AD has significantly advanced our understanding of brain functions and AD mechanisms.\\
\\
Beyond her foundational research, Ip is committed to translating discoveries into clinical applications, collaborating with international biopharmaceutical companies to develop potential drug leads for neurodegenerative diseases. She has also utilized AD biomarkers  and gene editing technology to enhance diagnostic and therapeutic development, further bridging the gap between research and clinical practice.\\ \\[{ALLOW view All}][{ALLOW edit nip}][{ALLOW upload nip}][{ALLOW comment All}]